Veradermics (MANE): Viking Global opened a new position $107M

1.69M

Shares reported

0.30%

Disclosed portfolio weight

$107M

Reported value

Holdings as of

Mar 31, 2026

Filed

May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 30, 2026Company filing · Form 8-K · ResultsReported its results
2. Apr 27, 2026Company filing · Form 8-K · ResultsReported its results
3. May 1, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them
4. May 12, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Aug 11, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Veradermics

For Veradermics, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MANE page.

How this filing works

• SEC Form 13F

Other disclosures at Veradermics

• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 13, 2026
• SEC Schedule 13DNov 13, 2026
• SEC Form 144Nov 11, 2026

Everything OQRO holds on this company is on its MANE page.